SQUAWK/NEWS
Account
Account
Menu
Live NewsCategoriesequity

LENZ Therapeutics, Inc. (LENZ) News

Track canonical SquawkNews coverage tagged to LENZ, LENZ Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 6 indexed stories across 4 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol LENZ Asset equity Sector Markets 90 days 6 Last 5.22 Updated Aug 11, 2026, 08:12 PM UTC Open live news feed
L LENZ Therapeutics Q2 EPS $(1.02) Beats $(1.06) Estimate, Sales $5.486M Beat $2.373M Estimate LENZ Therapeutics (NASDAQ: LENZ ) reported quarterly losses of $(1.02) per share which beat the analyst consensus estimate of $(1.06) by 3.77 percent. This is a 92.45 percent decrease over losses of $(0.53) per share fro EARNINGS | Aug 11, 2026, 08:12 PM UTC L LENZ - LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights LENZ - LENZ Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Highlights EARNINGS | Aug 11, 2026, 08:07 PM UTC L LENZ - LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026 - Click For Rele LENZ - LENZ Therapeutics to Report Second Quarter 2026 Financial Results and Recent Corporate Highlights on August 11, 2026 EARNINGS | Aug 04, 2026, 08:05 PM UTC L LENZ Therapeutics Announces Launch of New Telehealth Prescribing Option to Accelerate Patient Access to VIZZ® for the Treatment of Presbyopi VIZZ is now available for those who qualify through a convenient telehealth platform in EQUITY | Jul 06, 2026, 12:15 PM UTC M LENZ Expands Eye Drug Reach LENZ Therapeutics announces an exclusive licensing and commercialization agreement with Arrotex Pharmaceuticals for its eye drop therapy in Australia and New Zealand EQUITY | Jun 24, 2026, 05:41 PM UTC M LENZ Licenses VIZZ LENZ Therapeutics and Arrotex Pharmaceuticals announce exclusive license and commercialization agreement for VIZZ in Australia and New Zealand EQUITY | Jun 24, 2026, 12:30 PM UTC